Telmisartan Patent Expiration
Telmisartan is Used for the treatment of cardiovascular conditions such as myocardial infarction, hypertension, and stroke. It was first introduced by Boehringer Ingelheim
Telmisartan Patents
Given below is the list of patents protecting Telmisartan, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Micardis | US8003679 | Use of inhibitors of the renin-angiotensin system |
Oct 06, 2022
(Expired) | Boehringer Ingelheim |
| Micardis | US7998953 | Use of inhibitors of the renin-angiotensin system |
Jun 06, 2020
(Expired) | Boehringer Ingelheim |
| Micardis | US6358986 | Polymorphs of telmisartan |
Jan 10, 2020
(Expired) | Boehringer Ingelheim |
| Micardis | US5591762 | Benzimidazoles useful as angiotensin-11 antagonists |
Jan 07, 2014
(Expired) | Boehringer Ingelheim |
About Veterinary Telmisartan
Telmisartan is used in a drug marketed by 1 company: Boehringer Lngelheim Animal Health Usa Inc
Other drugs containing Telmisartan are: Semintra ,
Veterinary Telmisartan Patents
Given below is the list of patents protecting Telmisartan, along with the drug name that holds that patent and the company owning that drug.
Telmisartan's Family Patents
